Neurocrine Biosciences Inc (NBIX)
133.30
+0.30
(+0.23%)
USD |
NASDAQ |
Apr 17, 16:00
133.30
0.00 (0.00%)
After-Hours: 20:00
Neurocrine Biosciences Gross Profit Margin (Quarterly): 98.35% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 98.35% |
| September 30, 2023 | 97.75% |
| June 30, 2023 | 97.46% |
| March 31, 2023 | 97.98% |
| December 31, 2022 | 98.13% |
| September 30, 2022 | 98.43% |
| June 30, 2022 | 98.73% |
| March 31, 2022 | 98.52% |
| December 31, 2021 | 98.69% |
| September 30, 2021 | 98.58% |
| June 30, 2021 | 98.93% |
| March 31, 2021 | 98.77% |
| December 31, 2020 | 98.83% |
| September 30, 2020 | 98.96% |
| Date | Value |
|---|---|
| June 30, 2020 | 99.21% |
| March 31, 2020 | 99.11% |
| December 31, 2019 | 98.98% |
| September 30, 2019 | 99.01% |
| June 30, 2019 | 99.13% |
| March 31, 2019 | 99.21% |
| December 31, 2018 | 98.82% |
| September 30, 2018 | 98.98% |
| June 30, 2018 | 99.12% |
| March 31, 2018 | 98.66% |
| December 31, 2017 | 99.20% |
| September 30, 2017 | 99.29% |
| June 30, 2017 | 99.04% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
97.46%
Minimum
Jun 2023
99.21%
Maximum
Jun 2020
98.61%
Average
98.73%
Median
Jun 2022
Gross Profit Margin (Quarterly) Benchmarks
| Baxter International Inc | 37.89% |
| Azenta Inc | 39.86% |
| Hologic Inc | 56.02% |
| West Pharmaceutical Services Inc | 38.01% |
| Globus Medical Inc | 56.94% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.17% |
| Return on Assets | 9.29% |
| Return on Invested Capital | 12.09% |
| Profit Margin (Quarterly) | 28.67% |
| Operating Margin (Quarterly) | 29.17% |
| Return on Net Operating Assets | 38.13% |